RADIATION ONCOLOGY TRAINING PROGRAM
放射腫瘤科-放射腫瘤訓練課程
RADIATION ONCOLOGY TRAINING PROGRAM
放射腫瘤科-放射腫瘤訓練課程
The Department of Radiation Oncology is a leading center for precision radiotherapy in the Asia-Pacific region. As of May 2025, the department is equipped with four advanced radiotherapy systems, including two TomoTherapy® image-guided radiotherapy (IGRT) units, one Elekta Versa HD linear accelerator with four-dimensional image guidance (4D IGRT), and one Nucletron microSelectron® Digital high-dose-rate (HDR) Ir-192 brachytherapy system. In 2008, FEMH became the first dual-TomoTherapy center in Asia, establishing a major milestone in the development of advanced radiation therapy in the region.
The department treats more than 1,200 patients annually across a broad spectrum of malignancies and has published more than 107 peer-reviewed scientific articles demonstrating its clinical expertise and research achievements. Recognized as one of the Top TomoTherapy Reference Centers in the Asia-Pacific region, FEMH is also the only medical center in Taiwan to receive the SNQ National Quality Certification for TomoTherapy. The department actively promotes international collaboration and professional education, including providing TomoTherapy training to Sunway Hospital in Malaysia, which subsequently performed the country's first total skin irradiation using helical TomoTherapy in 2023.
Since 2023, the department has further expanded its precision radiotherapy program by developing stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). These high-precision, short-course treatment techniques deliver ablative radiation doses while minimizing treatment-related toxicity. To date, more than 400 patients have been treated using SRS and SBRT at FEMH.
The department has achieved numerous milestones in radiation oncology. In 2007, it successfully performed Asia's first whole bone marrow irradiation, becoming only the third center worldwide capable of delivering this highly specialized treatment. The team also collaborated with the University of Cambridge Hospitals in implementing the first helical bone marrow irradiation combined with bone marrow transplantation. In 2013, the department published the world's first report describing Helical Irradiation of Total Skin (HITS) for the treatment of refractory and extensive cutaneous lymphoma, establishing a new benchmark in advanced radiotherapy.
By August 2025, the department had accumulated experience from more than 8,500 helical TomoTherapy treatments and continues to serve as a leading demonstration and training center for precision radiotherapy in the Asia-Pacific region. Its sustained commitment to innovation has been recognized through multiple national awards, including the SNQ National Quality Certification for TomoTherapy (2016–2020), Heart-Sparing Radiotherapy for Breast Cancer (2021), and Stereotactic Radiosurgery / Stereotactic Body Radiotherapy: High-Precision TomoTherapy (2024). These achievements reflect the department's leadership in advancing safer, more precise, and more effective cancer treatment.
Duration: 2 weeks-6 months
Depending on having RT experience or not
Program fee: TWD 30,000 per month
Determined by the hosting department on a case-by-case basis.
Applicant Qualification
Applications will be reviewed based on the applicant's qualifications and professional background.
Observership Objective
Oncological Radiotherapy
Stereotactic radiosurgery (SRS)/ Stereotactic ablative radiotherapy(SABR) techniques
Special radiotherapy techniques:Total Marrow Irradiation (TMI), Total Body Irradiation (TBI), Helical Irradiation of Total skin (HITS) and Total scalp Irradiation
Skills
Image-guided radiation therapy (IGRT) using tomotherapy and linear accelerator.
Techniques of SRS
Techniques of SABR
Helical irradiation of TMI, TBI, HITS and Total scalp Irradiation